CN105267777A - Medicine for treating periodontitis - Google Patents
Medicine for treating periodontitis Download PDFInfo
- Publication number
- CN105267777A CN105267777A CN201410349290.0A CN201410349290A CN105267777A CN 105267777 A CN105267777 A CN 105267777A CN 201410349290 A CN201410349290 A CN 201410349290A CN 105267777 A CN105267777 A CN 105267777A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- rhizoma
- periodontitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating periodontitis. The medicine is prepared from the following raw materials by weight: 25-35 parts of raw gypsum, 6-12 parts of cortex moutan, 3-9 parts of rhizoma coptidis, 3-9 parts of rhizoma cimicifugae, 6-12 parts of radix scutellariae, 6-12 parts of rheum officinale, 8-12 parts of radix rehmanniae recen, 8-12 parts of coix seeds, and 6-12 parts of semen plantaginis. The medicine for treating periodontitis disclosed by the invention selects 9 natural traditional Chinese medicines for compatibility, and various raw material medicines are in synergistic effect to play roles in removing heat to cool blood, purging fire for removing toxin, tonifying stomach and promoting fluid, ascending up spleen-qi and yang, tonifying spleen and excreting dampness, invigorating the circulation of blood to remove stasis and the like; the medicine has an inhibitory effect on both viruses and bacteria and treats both cause and symptoms; the medicine is good in effect on treating periodontitis and is free from toxic and side effects; and the medicine is simple in preparation method, relatively short in treatment course, convenient in administration and low in cost, and the effective rate reaches more than or equal to 85%.
Description
Technical field
The present invention relates to Chinese medicine, specifically a kind of medicine for the treatment of periodontitis.
Background technology
The chronic inflammatory disease of the Periodontal Supporting Tissue that periodontitis is mainly caused by local factor.As gingivitis fails to treat in time, inflammation can be diffused into periodontal membrane, alveolar bone and cementum by gingiva to deep layer and develop into periodontitis.Fundamental symptoms is for having Secondary cases gingival hemorrhage or halitosis, similar to symptoms of gingivitis.The swelling of visible gum edge, gum nipple and attached gingiva during inspection, matter are soft, in peony or kermesinus, visit and examine that easy hemorrhage occlusion is unable, dull pain, gingival hemorrhage, halitosis, submandibular lymph nodes enlargement, tenderness etc.Due to early stage how easily out in the cold without obvious subjective symptoms, comparatively serious in time having symptom, even can not retain tooth.
The traditional Chinese medical science is thought, periodontitis is mainly caused by steaming in stomach-fire, vital essence virtual loss, insufficiency of vital energy and blood.Heart-fire is flourishing, rising up of the stomach-fire, disarmony between the heart and kidney, and hyperactivity of deficient fire is fumigated and fallen ill in mouth.
Summary of the invention
The medicine of the treatment periodontitis the object of this invention is to provide a kind of good effect, the course for the treatment of is shorter, cost is low, having no side effect.
The technical scheme realizing the object of the invention is:
Treating a medicine for periodontitis, is be made up of the raw material of following weight proportioning:
Gypsum Fibrosum 25-35 part, Cortex Moutan 6-12 part, Rhizoma Coptidis 3-9 part, Rhizoma Cimicifugae 3-9 part, Radix Scutellariae 6-12 part, Radix Et Rhizoma Rhei 6-12 part, Radix Rehmanniae 8-12 part, Semen Coicis 8-12 part, Semen Plantaginis 6-12 part.
Preferably, the optimum weight proportioning of each raw material is:
Gypsum Fibrosum 30 parts, Cortex Moutan 9 parts, Rhizoma Coptidis 6 parts, Rhizoma Cimicifugae 6 parts, Radix Scutellariae 9 parts, Radix Et Rhizoma Rhei 9 parts, 10 parts, the Radix Rehmanniae, Semen Coicis 10 parts, Semen Plantaginis 9 parts.
Described crude drug is in shop of Chinese medicines and commercially available.
The preparation method of medicine of the present invention, can decoct into decoction according to a conventional method, and concrete grammar is: take each crude drug by weight ratio, adds the water of 5-10 times of crude drug total amount, boils rear slow fire and boils 10-20 minute, filter and remove residue, to obtain final product with big fire.
Instructions of taking: every day three times, one after each meal, each 25 milliliters, general 3-5 day and effective.
Medicine of the present invention also can be made into pill, powder or capsule.
In the present invention, effect of each crude drug is as follows:
Gypsum Fibrosum: pungent, sweet, cold nature.Attach to the lung and stomach meridians.The effects such as have clearing away heat-fire, relieving restlessness is quenched the thirst, convergence granulation promoting.
Cortex Moutan: acrid in the mouth, hardship, cool in nature, enter the heart, liver, kidney channel.There is effect of clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.
Rhizoma Coptidis: bitter in the mouth, cold in nature, GUIXIN, liver, stomach, large intestine channel.There is the effects such as clearing away heat-fire, dampness, removing toxic substances.Cure mainly calentura burning hot, high heat is irritated, hyperactivity of heart-fire, aphtha of the mouth and tongue, bleeding due to blood-heat, gingival swelling and pain, pathopyretic ulcer, and eczema is scalded.
Rhizoma Cimicifugae: acrid in the mouth, sweet, cold nature, returns lung, spleen channel, large intestine, stomach warp.There is heat-clearing and toxic substances removing, deliver the effect such as rash, ascending up spleen-Qi and Yang.
Radix Scutellariae: bitter in the mouth, cold in nature, return lung, gallbladder, spleen, stomach, large intestine, small intestine meridian.Have heat clearing and damp drying, eliminating fire and detoxication, hemostasis, etc. effect.
Radix Et Rhizoma Rhei: bitter in the mouth, cold in nature, return spleen, stomach, large intestine, liver, pericardium channel.Have and attack the effects such as stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, removing toxic substances.
The Radix Rehmanniae: sweet in the mouth, cold in nature, GUIXIN, liver, kidney channel.There is heat clearing away, promote the production of body fluid, moisturize, laxation, removing blood stasis with potent drugs, tissue regeneration promoting, pain relieving, regulating menstruation, the incised wound stasis of blood, removing heat from blood, stop blooding, the effect such as to invigorate blood circulation.
Semen Coicis: sweet in the mouth, light, cold in nature, returns spleen, lung, kidney channel.There is the function such as spleen invigorating eliminating dampness by diuresis, eliminating impediment antidiarrheal.
Semen Plantaginis: sweet in the mouth, cold in nature, return liver, kidney, lung, small intestine meridian.There is clearing away heat and promoting diuresis, removing heat from blood, heat-clearing and toxic substances removing, liver heat removing and eyesight improving, eliminate the phlegm, effect of antidiarrheal.
9 kinds of natural Chinese medicine compatibilities chosen by the medicine that the present invention treats periodontitis, each crude drug synergism plays the effects such as clearing away heat and cooling blood, eliminating fire and detoxication, reinforcing stomach reg fluid, ascending up spleen-Qi and Yang, spleen invigorating eliminating dampness by diuresis, promoting blood circulation to remove blood stasis, inhibitory action is had to virus and antibacterial, treating both the principal and the secondary aspects of a disease at the same time, effective to treatment periodontitis, have no side effect.And its preparation method is simple, the course for the treatment of is shorter, taking convenience, cost is low, and effective percentage reaches more than 85%.
Detailed description of the invention
Below in conjunction with embodiment, content of the present invention is further described, but is not limitation of the invention.
Embodiment 1:
Treat a medicine for periodontitis, the weight proportion of each raw material is:
Gypsum Fibrosum 25 parts, Cortex Moutan 6 parts, Rhizoma Coptidis 3 parts, Rhizoma Cimicifugae 3 parts, Radix Scutellariae 6 parts, Radix Et Rhizoma Rhei 6 parts, 8 parts, the Radix Rehmanniae, Semen Coicis 8 parts, Semen Plantaginis 6 parts.Decoct into decoction oral according to a conventional method.
Embodiment 2:
Treat a medicine for periodontitis, the weight proportion of each raw material is:
Gypsum Fibrosum 30 parts, Cortex Moutan 9 parts, Rhizoma Coptidis 6 parts, Rhizoma Cimicifugae 6 parts, Radix Scutellariae 9 parts, Radix Et Rhizoma Rhei 9 parts, 10 parts, the Radix Rehmanniae, Semen Coicis 10 parts, Semen Plantaginis 9 parts.Decoct into decoction oral according to a conventional method.
Embodiment 3:
Treat a medicine for periodontitis, the weight proportion of each raw material is:
Gypsum Fibrosum 35 parts, Cortex Moutan 12 parts, Rhizoma Coptidis 9 parts, Rhizoma Cimicifugae 9 parts, Radix Scutellariae 12 parts, Radix Et Rhizoma Rhei 12 parts, 12 parts, the Radix Rehmanniae, Semen Coicis 12 parts, Semen Plantaginis 12 parts.Decoct into decoction oral according to a conventional method.
Experimental example:
In order to prove the clinical efficacy of medicine of the present invention further, selecting 30 routine patients, clinical observation is carried out to the curative effect of medicine of the present invention.
Efficacy determination based on transference cure, and changes situation with reference to effect etc., is divided into effective, effective and invalid.
Effective: symptom obviously alleviates and successful improves.
Effective: symptom and effect have certain improvement.
Invalid: symptom and sign are all without improvement or DeGrain.
Apply in Drug therapy periodontitis 30 example of the present invention, man 14 example, female 16 example.Fundamental symptoms is: halitosis, be engaged unable, gingival hemorrhage, submandibular lymph nodes enlargement, tenderness etc.After oral Drug therapy of the present invention, symptom all has certain improvement, wherein effective 27 examples, effective 30 examples, invalid 0 example, effective percentage 100%.
Claims (2)
1. treat a medicine for periodontitis, it is characterized in that being made up of the raw material of following weight proportioning: Gypsum Fibrosum 25-35 part, Cortex Moutan 6-12 part, Rhizoma Coptidis 3-9 part, Rhizoma Cimicifugae 3-9 part, Radix Scutellariae 6-12 part, Radix Et Rhizoma Rhei 6-12 part, Radix Rehmanniae 8-12 part, Semen Coicis 8-12 part, Semen Plantaginis 6-12 part.
2. medicine according to claim 1, is characterized in that the weight proportion of each raw material is: Gypsum Fibrosum 30 parts, Cortex Moutan 9 parts, Rhizoma Coptidis 6 parts, Rhizoma Cimicifugae 6 parts, Radix Scutellariae 9 parts, Radix Et Rhizoma Rhei 9 parts, 10 parts, the Radix Rehmanniae, Semen Coicis 10 parts, Semen Plantaginis 9 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410349290.0A CN105267777A (en) | 2014-07-22 | 2014-07-22 | Medicine for treating periodontitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410349290.0A CN105267777A (en) | 2014-07-22 | 2014-07-22 | Medicine for treating periodontitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105267777A true CN105267777A (en) | 2016-01-27 |
Family
ID=55138166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410349290.0A Pending CN105267777A (en) | 2014-07-22 | 2014-07-22 | Medicine for treating periodontitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105267777A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3459555A4 (en) * | 2016-05-18 | 2019-03-27 | Nippon Zettoc Co., Ltd. | Composition for oral cavity |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152335A (en) * | 2007-09-20 | 2008-04-02 | 吴月 | Traditional Chinese medicine for treating acute gingivitis |
CN102423428A (en) * | 2011-12-13 | 2012-04-25 | 赵丹 | Chinese medicine composition for treating periodontitis |
-
2014
- 2014-07-22 CN CN201410349290.0A patent/CN105267777A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152335A (en) * | 2007-09-20 | 2008-04-02 | 吴月 | Traditional Chinese medicine for treating acute gingivitis |
CN102423428A (en) * | 2011-12-13 | 2012-04-25 | 赵丹 | Chinese medicine composition for treating periodontitis |
Non-Patent Citations (2)
Title |
---|
刘平: "清胃汤治疗牙周病58例", 《山东中医杂志》 * |
金福兴等: "《口腔疾病效方300首》", 31 May 2004 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3459555A4 (en) * | 2016-05-18 | 2019-03-27 | Nippon Zettoc Co., Ltd. | Composition for oral cavity |
US10603271B2 (en) | 2016-05-18 | 2020-03-31 | Nippon Zettoc Co., Ltd. | Oral composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103610850A (en) | Medicine for treating hyperlipemia | |
CN104758487A (en) | Traditional Chinese medicine composition for treating exfoliative cheilitis | |
CN102198247A (en) | Formula of Chinese medicine for treating whelk | |
CN104667035A (en) | Medicament for treating gout | |
CN103610964A (en) | Medicine for treating recurrent oral ulcer | |
CN103611126A (en) | Medicine for treating ascariasis | |
CN105267777A (en) | Medicine for treating periodontitis | |
CN107213242A (en) | A kind of paste for being used to treat eczema | |
CN101204525B (en) | Tincture medicine for burn | |
CN103417782A (en) | Traditional Chinese medicine for treating scald | |
CN102370817B (en) | Medicine decoction for treating light-headedness | |
CN101574474A (en) | Traditional Chinese medicine composition for curing purpura | |
CN105434906A (en) | Drug for treatment of mouth and tongue sore | |
CN101199654B (en) | Chinese medicine for oral administration for treating periodontitis | |
CN105288326A (en) | Insomnia treatment medicine | |
CN104922476A (en) | Drug for treating gingivitis | |
CN104740158A (en) | Medicine for treating hyperthyroidism | |
CN105311445A (en) | Medicine for treating acute pulpitis | |
CN105362366A (en) | Medicine for treating acute mastitis | |
CN102872211B (en) | Chinese medicine for treating epistaxis and preparation method thereof | |
CN102698195B (en) | Radix-curcumae traditional Chinese medicinal oral liquid for treating chronic hepatitis and preparation method | |
CN104721286A (en) | Gingivitis treatment traditional Chinese medicine | |
CN103479974A (en) | Traditional Chinese medicine for treating chilblain | |
CN105311235A (en) | Traditional Chinese medicine washing liquor for treating hemorrhoids | |
CN107837357A (en) | A kind of Chinese medicine composition for being used to treat nettle rash |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160127 |
|
WD01 | Invention patent application deemed withdrawn after publication |